[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information to accompany humanitarian device exemption applications.[ Price : $8.95]
Federal Register Notice: FDA extends the expiration date on a compliance policy guide on radiofrequency identification feasibility...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance, Enrichment Strategies for Clinical Trials to Support Approval of Human Dru...[ Price : $8.95]
Federal Register Notice: FDA releases additional product-specific guidance on the design of bioquivalence studies to support ANDAs...[ Price : $8.95]
Antares Pharma submits an NDA for Otrexup, a combination product for delivering methotrexate using Medi-Jet technology.[ Price : $8.95]
FDA approves a GlaxoSmithKline BLA for Fluarix Quadrivalent (influenza virus vaccine) for the immunization of children (three year...[ Price : $8.95]
Three months ahead of its user fee review date, FDA approves an Ariad Pharmaceuticals NDA for Iclusig to treat adults with two for...[ Price : $8.95]
FDA approves Human Genome Sciences raxibacumab injection to treat inhalational anthrax.